Healthcare

Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. This customer research was completed to understand trends, dynamics, and parameters specific to the delivery of drugs to cancer patients; identify physicians prescribing trends relative to delivery considerations; understand the role of reimburs...

This issue of Vital Signs, released on September 26, 2012, provides an insight in to the research antibodies market place. The survey captures the purchasing, budget, application, and technology trends of research antibody use. Additionally, the survey determines customer ratings of suppliers, supplier usage, unmet needs, and challenges.

The following market insight provides a review of four companies' approaches to adding value to the molecular diagnostics market. These vendors employed one of four strategies: lowing the cost of molecular diagnostics manufacturing, improving upon the molecular diagnostics sample preparation process, combining established molecular diagnostic techn...

The following market insight provides an overview of the current state of the advanced visualization market in the U.S., evaluating the current adoption of enterprise solutions replacing conventional stand-alone solutions. It also provides an analysis of the competitive dynamics shaping up the advanced visualization industry in the U.S., in light o...

The continuing convergence of healthcare and information communication technologies makes the telehealth industry one of the most confusing yet transformative spaces in the world. Despite many hurdles, telehealth markets continue to be an effective treatment for many shortfalls present in the current healthcare experience, whether it is getting to...

This research service covers the therapeutics for rheumatic diseases market in the United States from 2009 to 2017, with 2011 as the base year. The focus of this research is on biologics and other treatments prescribed as add-on therapies for rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS); background standard ...

This research service considers products and companies in the obesity surgery devices market in the United States. The market is expected to see many technology advancements in the next decade. Therefore, a thorough understanding of revenue forecasts, unit forecasts, technological advances, and pricing analyses are provided for the markets various...

This deliverable provides insights on the many macro issues facing the life sciences industry which have resulted in consolidation and an increasing number in partnerships. This research service presents merger and acquisition activity by select life sciences participants and business strategies for new drug development, including contract research...

This issue of Vital Signs, released on August 20, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.